Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1

Journal of Virology

Volumn 79, Issue 21, 2005, Pages 13572-13578

  Althaus, Christian L ^a,b   Bonhoeffer, Sebastian ^a  

^a ETH ZURICH   (Switzerland)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; EFFECTIVE POPULATION SIZE; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION RATE; POPULATION GENETICS; PRIORITY JOURNAL; SIMULATION; STOCHASTIC MODEL; THEORY; VIRUS MUTANT; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; EVOLUTION; HIV-1; MATHEMATICS; MUTATION; RECOMBINATION, GENETIC; STOCHASTIC PROCESSES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 27144440023     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.21.13572-13578.2005     Document Type: Article

References (42)

1. Achaz, G., S. Palmer, M. Kearney, F. Maldarelli, J. W. Mellors, J. M. Coffin, and J. Wakeley. 2004. A robust measure of HIV-1 population turnover within chronically infected individuals. Mol. Biol. Evol. 21:1902-1912.
2. Barton, N. H., and B. Charlesworth. 1998. Why sex and recombination? Science 281:1986-1990.
3. Bonhoeffer, S., C. Chappey, N. T. Parkin, J. M. Whitcomb, and C. J. Petropoulos. 2004. Evidence for positive epistasis in HIV-1. Science 306:1547-1550.
4. Bonhoeffer, S., R. M. May, G. M. Shaw, and M. A, Nowak. 1997. Virus dynamics and drug therapy. Proc. Natl. Acad. Sci. USA 94:6971-6976.
5. Bonhoeffer, S., and M. A. Nowak. 1997. Pre-existence and emergence of drug resistance in HIV-1 infection. Proc. R. Soc. Lond. B Biol. Sci. 264:631-637.
6. Bretscher, M. T., C. L. Althaus, V. Muller, and S. Bonhoeffer. 2004. Recombination in HIV and the evolution of drug resistance: for better or for worse? Bioessays 26:180-188.
7. Burke, D. S. 1997. Recombination in HIV: an important viral evolutionary strategy. Emerg. Infect. Dis. 3:253-259.
8. Christiansen, F. B., S. P. Otto, A. Bergman, and M. W. Feldman. 1998. Waiting with and without recombination: the time to production of a double mutant. Theor. Popul. Biol. 53:199-215.
9. Fisher, R. A. 1930. The genetical theory of natural selection. Clarendon Press, Oxford, United Kingdom.
10. Frost, S. D., M. J. Dumaurier, S. Wain-Hobson, and A. J. Brown. 2001. Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc. Natl. Acad. Sci. USA 98:6975-6980.
11. Frost, S. D. W., M. Nijhuis, R. Schuurman, C. A. B. Boucher, and A. J. L. Brown. 2000. Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection. J. Virol. 74:6262-6268.
12. Fu, Y. X. 2001. Estimating mutation rate and generation time from longitudinal samples of DNA sequences. Mol. Biol. Evol. 18:620-626.
13. Funk, G. A., M. Fischer, B. Joos, M. Opravil, H. F. Gunthard, B. Ledergerber, and S. Bonhoeffer. 2001. Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. J. Acquir. Immune Defic. Syndr. 26:397-404.
14. Gu, Z., Q. Gao, E. A. Faust, and M. A. Wainberg. 1995. Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC. J. Gen. Virol. 76:2601-2605.
15. Haase, A. T., K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z. Q. Zhang, P. J. Dailey, H. H. J. Balfour, A. Erice, and A. S. Perelson. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274:985-989.
16. Harrigan, P. R., S. Bloor, and B. A. Larder. 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72:3773-3778.
17. Haiti, D. L., and A. G. Clark. 1997. Principles of population genetics, 3rd ed. Sinauer Associates, Sunderland, Mass.
18. Ho, D. D., A. V. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
19. Iles, M. M., K. Walters, and C. Cannings. 2003. Recombination can evolve in large finite populations given selection on sufficient loci. Genetics 165; 2249-2258.
20. Jung, A., R. Maier, J.-P. Vartanian, G. Bocharov, V. Jung, U. Fischer, E. Meese, S. Wain-Hobson, and A. Meyerhans. 2002. Multiply infected spleen cells in HIV patients. Nature 418:144.
21. Kellam, P., and B. A. Larder. 1995. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J. Virol. 69:669-674.
22. Leigh Brown, A. J. 1997. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94:1862-1865.
23. Leigh Brown, A. J., and D. D. Richman. 1997. HIV-1: gambling on the evolution of drug resistance? Nat. Med. 3:268-271.
24. Mansky, L. M. 2002. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug. Resist. Updates 5:219-223.
25. Mansky, L. M., and L. C. Bernard. 2000.3′-Azido-3′- deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. J. Virol. 74:9532-9539.
26. Mansky, L. M., D. K. Pearl, and L. C. Gajary. 2002. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. J. Virol. 76:9253-9259.
27. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
28. Morgan, T. H. 1913. Heredity and sex. Columbia University Press, New York, N.Y.
29. Moutouh, L., J. Corbeil, and D. D. Richman. 1996. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc. Natl. Acad. Sci. USA 93:6106-6111.
30. Muller, H. J. 1932. Some genetic aspects of sex. Am. Nat. 66:118-138.
31. Nijhuis, M., C. A. Boucher, P. Schipper, T. Leitner, R. Schuurman, and J. Albert. 1998. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc. Natl. Acad. Sci. USA 95:14441-14446.
32. Novick, A., and L. Szilard. 1951. Virus strains of identical phenotype but different genotype. Science 113:34-35.
33. Otto, S. P., and N. H. Barton. 2001. Selection for recombination in small populations. Evol. Int. J. Org. Evol. 55:1921-1931.
34. Otto, S. P., and T. Lenormand. 2002. Resolving the paradox of sex and recombination. Nat. Rev. Genet. 3:252-261.
35. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho, 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
36. Ribeiro, R. M., and S. Bonhoeffer. 2000. Production of resistant HIV mutants during antiretroviral therapy. Proc. Natl. Acad. Sci. USA 97:7681-7686.
37. Rodrigo, A. G., E. G. Shpaer, E. L. Delwart, A. K. Iversen, M. V. Gallo, J. Brojatsch, M. S. Hirsch, B. D. Walker, and J. I. Mullins. 1999. Coalescent estimates of HIV-1 generation time in vivo. Proc. Natl. Acad. Sci. USA 96:2187-2191.
38. Rouzine, I. M., and J. M. Coffin. 1999. Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl. Acad. Sci. USA 96:10758-10763.
39. Seo, T.-K., J. L. Thorne, M. Hasegawa, and H. Kishino. 2002. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. Genetics 160:1283-1293.
40. Shriner, D., R. Shankarappa, M. A. Jensen, D. C. Nickle, J. E. Mittler, J. B. Margolick, and J. I. Mullins. 2004. Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection. Genetics 166:1155-1164.
41. Stafford, M. A., L. Corey, Y. Cao, E. S. Daar, D. D. Ho, and A. S. Perelson. 2000. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203:285-301.
42. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, and B. H. Hahn. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.